ETH-155008
ETH-155008-101
Phase 1 small_molecule terminated
Quick answer
ETH-155008 for NHL is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- NHL
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated